No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anemia, Aplastic / blood
-
Anemia, Aplastic / chemically induced*
-
Anemia, Aplastic / immunology
-
Antibodies, Monoclonal
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
CTLA-4 Antigen / antagonists & inhibitors
-
CTLA-4 Antigen / immunology
-
Female
-
Humans
-
Ipilimumab / administration & dosage
-
Melanoma / blood
-
Melanoma / drug therapy*
-
Melanoma / immunology
-
Melanoma / pathology
-
Middle Aged
-
Neoplasm Metastasis
-
Nivolumab
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors
-
Programmed Cell Death 1 Receptor / immunology
Substances
-
Antibodies, Monoclonal
-
CTLA-4 Antigen
-
CTLA4 protein, human
-
Ipilimumab
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor
-
Nivolumab